Tema Oncology ETFCANCETF
13F holders, Q3 2025 (September 30)6holders +1
3new positions
2sold out
$28.71avg. 13F price*
At the end of Q3 2025, 6 institutions reported holding Tema Oncology ETF (CANC) in their 13F filings, up 1 from Q2 2025. 3 opened new positions and 2 sold out. The largest holders were Thrivent Financial for Lutherans ($4.2M), Flow Traders U.S. LLC ($630K) and UBS Group AG ($17K).
- Company
- Tema Oncology ETF
- Filed as
- TEMA ETF TRUST (Q3 2025)
- CUSIP
- 87975E701
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $658K |
| Exits | 2 | $370K |
All 13F filers, Q2 2025 → Q3 2025: 22,920 shares bought and 824,982 shares sold, net −802,062 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Thrivent Financial for Lutherans | 0.01% | Reduce -84.6% | 147,472 | $4.2M |
| Flow Traders U.S. LLC | 0.03% | New | 21,939 | $630K |
| UBS Group AG | 0.00% | New | 605 | $17K |
| TD Capital Management LLC | 0.00% | New | 376 | $11K |
| Osaic Holdings, Inc. | 0.00% | No change | 370 | $11K |
| Principal Securities, Inc. | 0.00% | No change | 50 | $1K |
"% of holder's portfolio" is CANC's weight in each manager's 13F, not the share of Tema Oncology ETF the manager owns.